How does roxithromycin compare to amoxicillin for the treatment of streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Roxithromycin is NOT Recommended Over Amoxicillin for Streptococcal Pharyngitis

Amoxicillin remains the preferred first-line treatment for group A streptococcal pharyngitis, and roxithromycin (a macrolide) should only be considered as an alternative in penicillin-allergic patients. 1

Why Amoxicillin is Superior

The 2012 IDSA guidelines explicitly state that penicillin or amoxicillin is the recommended drug of choice based on:

  • Narrow spectrum of activity (reduces antimicrobial resistance)
  • Infrequency of adverse reactions
  • Modest cost
  • Proven efficacy and safety
  • No documented penicillin resistance in Group A Streptococcus 1, 2

Amoxicillin is FDA-approved for upper respiratory tract infections caused by Streptococcus species, including streptococcal pharyngitis 2. The standard regimen is 10 days of treatment to achieve maximal pharyngeal eradication of GAS.

Roxithromycin's Limited Role

Roxithromycin, as a macrolide antibiotic, falls into the category of second-line agents reserved for penicillin-allergic patients. The IDSA guidelines recommend macrolides (clarithromycin for 10 days or azithromycin for 5 days) only when patients cannot tolerate penicillin or amoxicillin 1.

Evidence Comparing the Two:

The available research comparing roxithromycin to amoxicillin shows:

  • No superiority for roxithromycin: A 2002 double-blind RCT in lower respiratory tract infections found that roxithromycin showed no surplus value over amoxicillin, with amoxicillin remaining "a reliable first-choice antibiotic" 3

  • Similar efficacy but broader spectrum concerns: While a 1992 study showed similar clinical response rates (96% vs 95%), this doesn't justify using a broader-spectrum macrolide when narrow-spectrum amoxicillin is equally effective 4

Critical Considerations

Antimicrobial Stewardship

Using broad-spectrum antibiotics like macrolides when narrow-spectrum agents work equally well contributes to:

  • Development of antibiotic-resistant organisms
  • Disruption of normal flora
  • Increased healthcare costs

There is significant resistance to macrolides (azithromycin and clarithromycin) in some parts of the United States 5, making their routine use even more problematic.

When to Consider Macrolides (Including Roxithromycin)

Only use macrolides for streptococcal pharyngitis when:

  • Documented penicillin allergy (non-anaphylactic reactions can use first-generation cephalosporins instead)
  • True anaphylactic penicillin allergy where cephalosporins are also contraindicated 1

Clinical Algorithm

  1. Confirm GAS pharyngitis with rapid antigen test or culture

  2. Assess penicillin allergy status:

    • No allergy: Use amoxicillin 50 mg/kg once daily (max 1000 mg) for 10 days 1
    • Non-anaphylactic allergy: Use first-generation cephalosporin for 10 days 1
    • Anaphylactic allergy: Use clindamycin or clarithromycin for 10 days, or azithromycin for 5 days 1
  3. Roxithromycin would only fit in the third category as a macrolide alternative

Bottom Line

There is no evidence-based justification for choosing roxithromycin over amoxicillin as first-line therapy for streptococcal pharyngitis. The guideline-recommended approach prioritizes amoxicillin for its narrow spectrum, proven efficacy, safety profile, and role in antimicrobial stewardship 1, 6. Recent evidence even questions whether antibiotics provide substantial benefit beyond symptom reduction of 1-2 days 7, making the choice of the narrowest effective spectrum even more critical when treatment is indicated.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.